Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinglin Wang

Showing results (41-50 of 300) with videos related to

Pageof 30
Sort By:
Human Vaccines & Immunotherapeutics|July 10, 2013
A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemiaQing Li, Wenwen Xin, Shan Gao, et al.
Journal of Nanobiotechnology|April 30, 2026
Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systemsYanan Zhang, Yawen Zhu, Yun Yang, et al.
Smart Medicine|August 27, 2024
Modification and crosslinking strategies for hyaluronic acid-based hydrogel biomaterialsZhiqiang Luo, Yu Wang, Ye Xu, et al.
Smart Medicine|August 27, 2024
Roles of N6-methyladenosine epitranscriptome in non-alcoholic fatty liver disease and hepatocellular carcinomaYuyan Chen, Zhengyi Zhu, Lu Zhang, et al.
ACS Nano|June 25, 2024
Emerging mRNA Technology for Liver Disease TherapyJi Wang, Yile Fang, Zhiqiang Luo, et al.
Acta Crystallographica. Section E, Structure Reports Online|February 15, 2014
(E)-N'-(2-Chloro-benzyl-idene)-1-methyl-4-nitro-1H-pyrrole-2-carbohydrazideJinglin Wang, Rong He, Zhijuan Xin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 19, 2024
Biomimetic Liver Lobules from Multi-Compartmental MicrofluidicsDanqing Huang, Zhuhao Wu, Ji Wang, et al.
Journal of Pharmaceutical Policy and Practice|February 19, 2025
Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trialYiling Ding, Chunping Wang, Yamin Shu, et al.
Cell Death & Disease|May 21, 2022
Antibiotic pretreatment attenuates liver ischemia-reperfusion injury by Farnesoid X receptor activationHanyi Liu, Jinglin Wang, Yitao Ding, et al.
Stem Cell Research & Therapy|January 8, 2021
Mesenchymal stem cell-secreted prostaglandin E<sub>2</sub> ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarizationJinglin Wang, Yang Liu, Haoran Ding, et al.
Pageof 30

Showing results (41-50 of 300) with videos related to

Sort By:
Pageof 30
Human Vaccines & Immunotherapeutics|July 10, 2013
A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemiaQing Li, Wenwen Xin, Shan Gao, et al.
Journal of Nanobiotechnology|April 30, 2026
Engineered live bacteria for liver diseases and gut-liver axis disorders: from genetic modification to advanced delivery systemsYanan Zhang, Yawen Zhu, Yun Yang, et al.
Smart Medicine|August 27, 2024
Modification and crosslinking strategies for hyaluronic acid-based hydrogel biomaterialsZhiqiang Luo, Yu Wang, Ye Xu, et al.
Smart Medicine|August 27, 2024
Roles of N6-methyladenosine epitranscriptome in non-alcoholic fatty liver disease and hepatocellular carcinomaYuyan Chen, Zhengyi Zhu, Lu Zhang, et al.
ACS Nano|June 25, 2024
Emerging mRNA Technology for Liver Disease TherapyJi Wang, Yile Fang, Zhiqiang Luo, et al.
Acta Crystallographica. Section E, Structure Reports Online|February 15, 2014
(E)-N'-(2-Chloro-benzyl-idene)-1-methyl-4-nitro-1H-pyrrole-2-carbohydrazideJinglin Wang, Rong He, Zhijuan Xin, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 19, 2024
Biomimetic Liver Lobules from Multi-Compartmental MicrofluidicsDanqing Huang, Zhuhao Wu, Ji Wang, et al.
Journal of Pharmaceutical Policy and Practice|February 19, 2025
Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trialYiling Ding, Chunping Wang, Yamin Shu, et al.
Cell Death & Disease|May 21, 2022
Antibiotic pretreatment attenuates liver ischemia-reperfusion injury by Farnesoid X receptor activationHanyi Liu, Jinglin Wang, Yitao Ding, et al.
Stem Cell Research & Therapy|January 8, 2021
Mesenchymal stem cell-secreted prostaglandin E<sub>2</sub> ameliorates acute liver failure via attenuation of cell death and regulation of macrophage polarizationJinglin Wang, Yang Liu, Haoran Ding, et al.
Pageof 30